Our patient was classified as MammaPrint high-risk with the lowest index possible (-1.0) and BluePrint basal-type, a tumor biology that resembles TNBC and most likely is not dependent on estrogen receptor signaling [12]. Here, ESR1 is linked to neoplasm.